Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations
Clinical trial NCT07738887 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07738887
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-31
- Primary completion
- 2029-12-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.